Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Hariri Robert J Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2023 4 Hariri Robert J (Director) has filed a Form 4 on Cryoport, Inc.
Txns: Granted 8,105 shares @ $0
Granted 15,125 options to buy @ $20.05, valued at $303.3k
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2022 4 Hariri Robert J (CEO) has filed a Form 4 on Celularity Inc
Txns: Bought 10,000 shares @ $1.7175, valued at $17.2k
11/29/2022 4 Hariri Robert J (CEO) has filed a Form 4 on Celularity Inc
Txns: Bought 40,000 shares @ $1.71, valued at $68.4k
11/28/2022 4 Hariri Robert J (CEO) has filed a Form 4 on Celularity Inc
Txns: Bought 40,000 shares @ $1.74, valued at $69.6k
08/25/2022 4 Hariri Robert J (CEO) has filed a Form 4 on Celularity Inc
Txns: Exercised 119,073 options to buy @ $2.87, valued at $341.7k
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2022 4 Hariri Robert J (CEO) has filed a Form 4 on Celularity Inc
Txns: Granted 131,234 shares @ $0
Granted 384,801 options to buy @ $10.16, valued at $3.9M
04/20/2022 4 Hariri Robert J (Director) has filed a Form 4 on BIOVIE INC.
Txns: Granted 122,250 options to buy @ $5.04, valued at $616.1k
09/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/13/2021 4 Hariri Robert J (CEO) has filed a Form 4 on Celularity Inc
Txns: Granted 2,690,079 options to buy @ $10.23, valued at $27.5M
07/26/2021 SC 13D Hariri Robert J reports a 8.2% stake in Celularity Inc.
07/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/16/2021 3 Hariri Robert J (CEO) has filed a Form 3 on GX Acquisition Corp.
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2020 4 Hariri Robert J (Director) has filed a Form 4 on Cryoport, Inc.
Txns: Granted 35,000 options to buy @ $18.02, valued at $630.7k
04/06/2020 4 Hariri Robert J (Director) has filed a Form 4 on MYOS RENS TECHNOLOGY INC.
Txns: Granted 3,306 shares @ $0
05/03/2019 4 Hariri Robert J (Director) has filed a Form 4 on Cryoport, Inc.
Txns: Granted 35,000 options to buy @ $14.35, valued at $502.3k
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2018 4 Hariri Robert J (Director) has filed a Form 4 on Cryoport, Inc.
Txns: Granted 35,000 options to buy @ $4.8, valued at $168k
Granted 35,000 options to buy @ $9.29, valued at $325.2k
01/05/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
12/21/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
12/16/2015 4 Hariri Robert J (Director) has filed a Form 4 on Bionik Laboratories Corp.
11/24/2015 4 Hariri Robert J (Director) has filed a Form 4 on Cryoport, Inc.
Txns: Granted 50,000 options to buy @ $2.66, valued at $133k
09/30/2015 4 Hariri Robert J (10% Owner) has filed a Form 4 on MYOS Corp
Txns: Bought 800 shares @ $2.65, valued at $2.1k
Bought 1,500 shares @ $2.7, valued at $4.1k
09/25/2015 4 Hariri Robert J (10% Owner) has filed a Form 4 on MYOS Corp
Txns: Bought 6,250 shares @ $2.36, valued at $14.8k
Bought 4,500 shares @ $2.48, valued at $11.2k
Bought 1,400 shares @ $2.69, valued at $3.8k
09/11/2015 4 Hariri Robert J (10% Owner) has filed a Form 4 on MYOS Corp
Txns: Bought 3,000 shares @ $1.75, valued at $5.3k
Bought 1,000 shares @ $1.65, valued at $1.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy